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Association of Cardiac Autonomic Neuropathy
With Subclinical Myocardial Dysfunction in
Type 2 Diabetes
Julian W. Sacre, BS,*† Bennett Franjic, MD,* Christine L. Jellis, MD,* Carly Jenkins, PHD,*
Jeff S. Coombes, PHD,† Thomas H. Marwick, MD, PHD*‡
Brisbane, Queensland, Australia; and Cleveland, Ohio
O B J E C T I V E S The purpose of this study was to investigate the independent association between
global cardiac autonomic neuropathy (CAN) and left ventricular (LV) dysfunction in addition to regional
associations of LV dysinnervation and function, in patients with type 2 diabetes mellitus (T2DM).
B A C KG ROUND CAN represents a potential mechanism in the etiology of nonischemic diabetic
cardiomyopathy.
METHOD S Clinical measures of CAN based on total spectral power of heart rate variability and cardiac
reﬂex testing and echocardiographic assessment of LV function were performed in 118 patients with type 2
diabetes mellitus. Systolic and diastolic function were deﬁned at rest and peak exercise using peak systolic
and peak early diastolic (Em) tissue velocities, calculated in 6 basal- and mid-segments using color tissue
Doppler. Iodine 123-metaiodobenzylguanidine imaging was performed in 33 patients to directly quantify
global (heart/mediastinum ratio) and regional LV sympathetic integrity.
R E S U L T S Patients with CAN demonstrated higher resting heart rate, systolic and mean blood
pressures, aortic stiffness, hemoglobin A1c, and urine albumin/creatinine ratio, in addition to lower peak
heart rate, chronotropic index, and exercise capacity. Diastolic function (Em) was associated with
CAN, evidenced by total spectral power (r  0.42, p  0.001) and heart/mediastinum ratio (r  0.41,
p  0.017). Diastolic function (Em) at rest and systolic function (peak systolic tissue velocity) at rest
and exercise were signiﬁcantly reduced in patients with CAN. Furthermore, total spectral power was
associated with Em independent of age, hypertension, metabolic factors, and other relevant
contributors to LV dysfunction (  0.20, p  0.035). Relative regional tracer deﬁcits indicative of
local denervation were predominant in the anterior and lateral walls (p  0.001). Associations with
regional Em, independent of global iodine 123-metaiodobenzylguanidine uptake, were identiﬁed
exclusively in mid-anterior (  0.45, p  0.01) and mid-lateral walls (  0.34, p  0.03). However,
no association was found between regional denervation and systolic or diastolic dyssynchrony.
CONC L U S I O N S The diastolic dysfunction of type 2 diabetes mellitus shows associations with both
regional markers of sympathetic integrity and clinical markers of autonomic neuropathy. (J Am Coll
Cardiol Img 2010;3:1207–15) © 2010 by the American College of Cardiology Foundation
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1208ubclinical myocardial disease in patients
with type 2 diabetes mellitus (T2DM) may
progress to heart failure in the absence of
ischemia and hypertension (1). The patho-
hysiology of this diabetic cardiomyopathy
DCM) has been attributed to a variety of mech-
nisms including cardiac autonomic neuropathy
CAN), which is related to adverse outcome
See page 1216
2–4) and may affect up to one-third of patients with
2DM (5). However, the independent association of
distinct autonomic cardiopathy with DCM has been
difficult to establish due to the similar etiol-
ogies of these conditions (6). Moreover, the
spectrum of left ventricular (LV) functional
abnormalities characterizing this syndrome
is not well defined. CAN has been related to
altered LV filling patterns in the presence of
preserved systolic function in patients with
type 1 (7–11) as well as T2DM (12). How-
ever, these findings may simply reflect the
parallel development of diabetic complica-
tions with poor metabolic control, and the
independence of the association has not
been investigated relative to factors with
known involvement in DCM. In addition,
the detection of concomitant systolic
dysfunction of early DCM in CAN may
require sensitive techniques such as tis-
sue Doppler imaging and exercise stress
responses (13).
Radionuclide imaging characterizes the
direct effects of autonomic dysinnervation
on the myocardium, which demonstrates
marked regional heterogeneity in diabetic
patients (14). However, associations of rela-
tive segmental denervation with regional
unctional deficits and mechanical dyssynchrony have
ot been investigated. In this study, we sought to: 1)
dentify the importance of CAN in the etiology of
yocardial functional abnormalities in patients with
2DM, including rest and exercise diastolic and
ystolic dysfunction, relative to other contributors; and
) determine whether the association reflects a distinct
utonomic cardiopathy, describing a causative rela-
ionship evidenced by regional associations of myocar-
ial sympathetic integrity with function. Myocardial
cintigraphy with the post-synaptic tracer iodine 123-
etaiodobenzylguanidine (123I-MIBG) characterized
he global and regional cardiac effects of CAN, which
athy
G
ne
ssion
llitusupplemented clinical assessment using heart rate dHR) variability and cardiac reflex testing. Associa-
ions were sought with sensitive markers of DCM at
est and during exercise.
E T H O D S
tudy population. Patients with T2DM (n  118)
ere enrolled for the study. Inclusion criteria were
s follows: apparently healthy and asymptomatic,
ge 40 years and older, and no history of cardiovas-
ular disease, cancer, psychiatric illness, or other
evere illness. Patients with an abnormal electrocar-
iogram were excluded. All patients provided writ-
en informed consent, and the study was approved
y hospital and university human research ethics
ommittees. Biochemical analyses of fasting blood
nd urine samples were performed according to
tandard hospital pathology laboratory protocols.
lood pressure (BP) was recorded in the supine
osition using a calibrated automatic cuff. Pulse
ave velocity (SphygmoCor, AtCor Medical, Syd-
ey, Australia) between carotid and femoral sites
as applied to measure aortic stiffness.
esting LV function. Resting echocardiography was
erformed using a standard commercial ultrasound
achine with a 2.5-MHz phased-array probe (Vivid
, GE Vingmed, Horten, Norway). Conventional and
olor tissue Doppler apical views were acquired by
tandard methods (13). Mitral inflow velocities were
ecorded using pulsed-wave Doppler echocardiogra-
hy. LV internal dimensions and wall thicknesses,
easured from 2-dimensional targeted M-mode
chocardiography, were used to calculate LV mass
sing Devereux’s formula (15). LV end-diastolic and
systolic volumes, measured by a modified Simpson
iplane method, were indexed to body surface area
nd used to derive stroke volume index, cardiac index
stroke volume index  HR), and ejection fraction.
olor tissue Doppler images were analyzed offline
sing commercial software (Echopac PC, GE Ving-
ed). Regional myocardial function, based on peak
ystolic (Sm), peak early diastolic (Em), and peak late
iastolic (Am) tissue velocity, was classified in 6 basal
nd 6 mid-LV segments (septal, lateral, anteroseptal,
osterior, inferior, and anterior walls) by generating
issue velocity profiles using a 5  10-mm2 sample
olume. Regional Em and Sm were expressed as
ercentages of normal regional velocity (16) for inves-
igation of associations with regional 123I-MIBG up-
ake. SDs of times to peak Sm and Em from the onset
f the QRS complex (measured in the 12 LV seg-
ents) were also recorded to define systolic andB B R E V I A T I O N S
N D A C R O N YM S
m late diastolic tissue
elocity
P blood pressure
AN cardiac autonomic
europathy
CM diabetic cardiomyop
m early diastolic tissue
elocity
bA1c hemoglobin A1c
/M ratio ratio of 123I-MIB
ptake in the heart and
ediastinum
R heart rate
23I-MIBG iodine
23-metaiodobenzylguanidi
m systolic tissue velocity
PECT single-photon emi
omputed tomography
2DM type 2 diabetes me
P total spectral power ofiastolic mechanical synchrony. Global systolic and
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1209iastolic dysfunction were classified by mean basal Sm
5.3 cm/s and mean basal Em 5.5 cm/s, respec-
ively, corresponding to 1 SD below mean normal
alues (16). Subsequent grading of diastolic dysfunc-
ion distinguished impaired relaxation (grade 1),
seudonormal (grade 2), and restrictive (grade 3)
lling patterns based on current guidelines (17).
xercise testing and echocardiography. Patients un-
erwent maximal treadmill exercise testing accord-
ng to the Bruce protocol with simultaneous mea-
urement of VO2peak by expired gas analysis. The
R response to exercise (chronotropic index) was
alculated by HR reserve (peak HR  resting HR)
s a percentage of age-predicted HR reserve (18).
Tissue velocities, ejection fraction and stroke
olume and cardiac indexes were measured post-
tress using the techniques employed at rest. Post-
xercise images were compared with the resting
chocardiogram to identify inducible wall motion
bnormalities. Patients with evidence of ischemia
ere excluded. Systolic functional reserve was as-
essed by augmentation in Sm, ejection fraction and
troke volume and cardiac indexes. Diastolic func-
ional reserve was defined by augmentation in Em.
issue velocity reserve values were indexed to rest-
ng levels, as described by Ha et al. (19).
ardiovascular autonomic function testing. Clinical
ssessment of CAN comprised a battery of 7
ndexes, including 3 HR variability parameters and
cardiac reflex tests (6,20). Examination of HR
ariability was performed according to a standard
rotocol (21) after a light meal and after withhold-
ng antihypertensive medications for 24 h. Spectral
ower was defined in very low- (0.04 Hz), low-
0.04 to 0.15 Hz), and high- (0.15 to 0.4 Hz)
requency bands. Total spectral power of HR vari-
bility (TP) was also calculated as a global marker of
ardiac autonomic function to be used in regression
nalyses. Cardiovascular reflex tests were performed
ccording to standard protocols (22) and included
-R interval variation during deep breathing (expi-
ation/inspiration ratio), Valsalva maneuver, and
tanding and the systolic BP response to standing.
bnormal results within the 7-test battery were
efined by age- and sex-based normal values for
R variability (21) and cardiac reflex tests (22),
ith the total number of abnormal results defining
he CAN score. The presence of CAN was deter-
ined by a CAN score of 2, encompassing
reviously described criteria for borderline and def-
nite CAN (6,20).
23I-MIBG imaging. Scintigraphic assessment of
AN using 123I-MIBG was performed in a subgroup an 33) composed of patients with CAN (n 7) and
ontrol patients matched by age and sex (n  26).
atients were pre-medicated with 600 mg potas-
ium perchlorate at 7 AM on the morning of the test
o block thyroid uptake of radioiodine and in-
tructed to abstain from drinking tea, coffee, and
lcohol. Imaging (Symbia, Siemens, Erlangen,
ermany) was performed using a low-energy, high-
esolution collimator. Anterior planar and single-
hoton emission computed tomography (SPECT)
32 projections for 50 s each) myocardial images
ere acquired 4 h after injection of 150 MBq of
23I-MIBG. Tracer activity (mean count per pixel)
as calculated in specific regions of interest. Global
ptake was defined by the ratio of 123I-MIBG
ptake in the heart and mediastinum (H/M ratio).
egional uptake was measured in 12 LV segments
anterior, lateral, inferior, and septal walls in basal,
id-, and apical segments), and expressed relative
o maximal regional tracer activity. To account for
ypical regional heterogeneity in 123I-MIBG up-
ake, a percentage of normal relative regional uptake
as then calculated based on previously reported
ata in healthy subjects (23).
tatistical analysis. Data were analyzed using SPSS
ersion 16.0 (SPSS, Inc., Chicago, Illinois) and ex-
ressed as mean SD or median (interquartile range)
here appropriate, after Kolmogorov-Smirnov assess-
ent of normality of distribution. HR variability
arameters achieved normality after log10 transforma-
ion. Categorical and normally distributed continuous
ariables were compared using the 2 test and inde-
endent t test, respectively. Skewed and ordinal vari-
bles were compared by the Mann-Whitney U test.
nalysis of covariance was used to adjust for relevant
roup differences at baseline. A 2-way between-
roups analysis of variance was applied to compare
egional 123I-MIBG uptake and LV function in myo-
ardial segments and walls and their interaction, with
onferroni adjustment for multiple post hoc compar-
sons. Linear associations were assessed by Pearson
orrelation coefficient or Spearman rank correlation
oefficient (r), where appropriate. Regional relation-
hips of 123I-MIBG uptake and synchrony were
ssessed by partial correlation to remove influences of
onfounding variables. Multiple linear regression was
erformed using the enter method. Statistical signifi-
ance was defined by p  0.05.
E S U L T S
nducible wall motion abnormalities were absent in
ll patients; however, 4 patients were excluded due
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1210o an abnormal electrocardiogram, leaving a study
opulation of 114 patients. CAN was identified in
6 patients (14%). Clinical and echocardiographic
ata are displayed in Tables 1 and 2. Patients with
AN demonstrated higher resting HR, systolic and
ean BPs, and aortic stiffness, in addition to lower
eak HR, chronotropic index, and exercise capacity.
igher hemoglobin A1c (HbA1c), indicating poorer
for the Study Population by CAN Status
Patients With
CAN (n  16)
Patients Without
CAN (n  98) p Value
63 9 59 9 0.12
6 (38) 62 (63) 0.055
/m2 30 4 30 5 0.68
, yrs 8 (5–17) 6 (5–9) 0.21
n 76 9 66 9 0.001
ure, mm Hg 141 19 125 15 0.001
sure, mm Hg 75 12 72 9 0.19
re, mm Hg 97 13 89 10 0.007
ion 14 (88) 66 (67) 0.10
locity, m/s 11.1 3.0 9.1 1.9 0.001
8.3 1.2 7.3 1.6 0.021
10.4 4.2 8.5 3.2 0.039
ol/l 4.7 1.1 4.5 1.1 0.48
ol/l 2.8 0.8 2.7 1.0 0.83
ol/l 1.0 0.3 1.1 0.3 0.43
l 1.7 0.8 1.6 0.9 0.57
75.0 17.0 73.0 16.0 0.72
5.5 2.2 5.2 1.7 0.60
inine ratio, g/mol 2.5 (1.1–9.7) 1.2 (0.5–2.6) 0.047
isease 0 0 —
6 (38) 21 (21) 0.16
1 (6) 10 (10) 0.62
y 1 (6) 13 (13) 0.43
11 (69) 63 (64) 0.73
5 (31) 13 (13) 0.067
5 (31) 30 (31) 0.96
7 (44) 26 (27) 0.16
3 (19) 6 (6) 0.082
ckers 2 (13) 8 (8) 0.57
11 (69) 52 (53) 0.24
s
ts/min 143 18 158 16 0.001
% 85 20 96 14 0.004
pressure, mm Hg 191 18 200 25 0.15
pressure, mm Hg 87 18 87 11 0.89
25 7 30 7 0.016
ian (interquartile range), or n (%) when appropriate.
erting enzyme; CAN  cardiac autonomic neuropathy; HDL  high-densityensity lipoprotein; VO2peak  peak exercise oxygen uptake.lycemic control, and higher urine albumin/
reatinine ratio, consistent with microvascular dys-
unction, were also observed in patients with CAN.
o remove the potentially confounding influence of
ypertension, group comparisons of myocardial
unction were corrected for mean arterial pressure.
In the subgroup assessed by 123I-MIBG scintigra-
hy, global myocardial sympathetic dysinnervation in
he 7 patients with CAN was evidenced by a de-
reased H/M ratio (1.6 0.2 vs. 1.8 0.2 in controls,
 0.01). In all patients in the subgroup, clinical
arkers of CAN correlated with global, but not
egional, markers of sympathetic integrity, evidenced
y TP (r 0.47, p 0.007 vs. H/M ratio) and CAN
core (r  0.52, p  0.002 vs. H/M ratio).
lobal CAN and LV diastolic function. Patients with
AN demonstrated significantly decreased resting
m and Em/Am ratio compared with patients
ithout CAN, despite a similar mitral inflow pat-
ern (Table 2). Moreover, patients with CAN
emonstrated more adverse diastolic dysfunction
rade (Table 3; grades 1 and 2 only). No differences
ere observed in exercise Em or Em/Am ratio. In
ll patients, positive associations between cardiac
utonomic function and resting diastolic function
ere evidenced by correlations of TP with Em
Fig. 1), Em/Am ratio (r  0.35, p  0.001), and
he ratio of early-to-late diastolic filling velocity
E/A ratio) (r  0.29, p  0.002). A higher CAN
core was also associated with reduced Em (r 
0.38, p  0.001), Em/Am ratio (r  0.33, p 
.001,) and E/A ratio (r  0.21, p  0.02).
imilarly to clinical markers of CAN, the H/M
atio was positively associated with Em (Fig. 1) and
he Em/Am ratio (r  0.37, p  0.04).
Independent associations with diastolic function
ere sought by entering TP into a model of
eterminants of Em (adjusted R2  0.37, p 
.001) with significant clinical and biochemical
orrelates (age, mean BP, HbA1c, aortic pulse wave
elocity), in addition to factors with known influ-
nce (sex, body mass index, history of hypertension,
nd metformin and insulin therapy) (24). Indepen-
ent predictors of Em included TP (  0.20, p 
.035), age (  0.46, p  0.001) and mean BP
  0.25, p  0.013).
lobal CAN and LV systolic function. Despite similar
esting ejection fraction and stroke volume and
ardiac indexes, patients with CAN had reduced
m (Table 2) and a higher proportion of systolic
ysfunction compared with patients without CAN
56% vs. 21%; p  0.003). Furthermore, peakTable 1. Clinical Data
Clinical parameters
Age, yrs
Male, n (%)
Body mass index, kg
Duration of diabetes
Heart rate, beats/mi
Systolic blood press
Diastolic blood pres
Mean arterial pressu
History of hypertens
Aortic pulse wave ve
Biochemistry
Hemoglobin A1c, %
Glucose, mmol/l
Total cholesterol, mm
LDL cholesterol, mm
HDL cholesterol, mm
Triglycerides, mmol/
Creatinine, mol/l
Urea, mmol/l
Urine albumin/creat
Diabetic complications
Peripheral vascular d
Renal impairment
Retinopathy
Peripheral neuropath
Treatment
Metformin
Insulin
Sulfonylureas
ACE inhibitors
-blockers
Calcium channel blo
Statins
Exercise hemodynamic
Peak heart rate, bea
Chronotropic index,
Peak systolic blood
Peak diastolic blood
VO2peak, ml/kg/min
Data are mean  SD, med
ACE  angiotensin-convxercise and reserve indexes of LV contractile func-
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1211ion, including Sm, ejection fraction, and cardiac
ndex, were significantly reduced in patients with
AN. Despite the absence of associations with
esting Sm, autonomic function markers correlated
ith measures of systolic functional reserve in all
atients. TP was positively associated with peak Sm
r 0.29, p 0.002), peak cardiac index (r 0.22,
 0.02), Sm reserve index (r  0.30, p  0.001),
nd cardiac index reserve (r  0.26, p  0.008).
igher CAN score was associated with reductions
n peak Sm (r  0.25, p  0.008), peak stroke
olume index (r  0.23, p  0.02), peak cardiac
ndex (r  0.35, p  0.001), peak ejection
raction (r  0.19, p  0.049), Sm reserve index
r  0.25, p  0.009), and cardiac index reserve
r  0.38, p  0.001). H/M ratio was associated
ith peak ejection fraction (r 0.38, p 0.03), but
o other systolic functional parameters.
To determine independent associations with sys-
olic functional reserve, TP was entered into a model
f determinants of Sm reserve index (adjusted R2 
.39, p  0.001), into which HbA1c was forced
longside clinical and biochemical correlates (age, sex,
ean BP, resting HR, history of hypertension, aortic
ulse wave velocity, LV mass index, chronotropic
ndex, triglycerides, creatinine, albumin, and met-
ormin, angiotensin-converting enzyme inhibitor, and
-blocker therapy). Independent predictors of Sm
eserve index included age (  0.23, p  0.035),
istory of hypertension (  0.20, p  0.048), LV
ass index (  0.19, p  0.024), and chronotropic
ndex (  0.19, p  0.042).
egional 123I-MIBG-SPECT and LV function. Due to a
igh incidence of artifact secondary to mesenteric
ptake of 123I-MIBG, regional data for inferior wall
egments was excluded. Moreover, 5 of 33 patients
n whom the H/M ratio was measured required
xclusion from regional analyses due to poor-quality
omograms. Based on 2-way analysis of variance
sing segment type (basal or mid) and myocardial
all classification (septal, anterior, or lateral), 123I-
IBG uptake was not significantly different in
asal and mid-segments, but varied across myocar-
ial walls (p  0.001). This variation was analyzed
eparately in basal and mid-segments due to an
nteraction effect (p  0.001). Post hoc compari-
ons in basal segments revealed significantly greater
racer activity in the septal wall (114  14% of
ormal) compared with both the anterior (85 
0%, p 0.001) and lateral (83 10%, p 0.001)
alls. Similarly in mid-segments, 123I-MIBG up-
ake was greater in septal (105  10%) compared
ith both anterior (92  9%, p  0.001) and tateral (88  9%, p  0.001) walls. Regional LV
unction demonstrated a different heterogeneous
attern, characterized by greater deficits of Em in
id- (68  26% of normal) compared with basal
egments (86  22%, p  0.001), but no differ-
nces between myocardial walls. Sm was also
ower in mid- (75  28%) compared with basal
egments (95  23%, p  0.001), but similar in
he 3 walls.
Borderline correlations of regional 123I-MIBG
ptake with regional Em were observed only in
Table 2. Echocardiography Data for the Study Population by CA
Patients With
CAN (n  16)
Patient
CAN (
Resting echocardiography
EDVI, ml/m2 33 9 35
ESVI, ml/m2 12 6 12
Stroke volume index, ml/m2 21 4 22
Cardiac index, l/min/m2 1.6 0.3 1.5
Ejection fraction, % 64 8 65
LV mass index, g/m2 72 16 83
Doppler
E, m/s 0.8 0.1 0.7
A, m/s 0.9 0.2 0.7
E/A ratio 0.9 0.2 1.0
DT, ms 225 50 217
Tissue Doppler
Sm, cm/s 5.3 0.5 6.1
Em, cm/s 4.7 1.0 6.3
Am, cm/s 7.2 1.0 7.1
Em/Am ratio 0.7 0.2 0.9
Exercise echocardiography
Peak EDVI, ml/m2 33 8 34
Peak ESVI, ml/m2 10 4 8
Peak stroke volume index, ml/m2 23 4 26
Peak cardiac index, l/min/m2 3.3 0.7 4.1
Peak ejection fraction, % 72 5 76
Tissue Doppler
Peak Sm, cm/s 8.6 1.9 10.8
Peak Em, cm/s 9.9 2.1 10.2
Peak Am, cm/s 10.5 2.0 10.8
Peak Em/Am ratio 0.9 0.2 0.9
Em reserve index, cm/s 3.9 1.8 3.2
LV contractile reserve
Stroke volume index reserve, ml/m2 3 4 4
Cardiac index reserve, l/min/m2 1.8 0.7 2.6
Ejection fraction reserve, % 7 5 11
Sm reserve index, cm/s 2.7 1.5 3.9
Data are mean SD. Doppler, tissue Doppler, and exercise echocardiographic va
mean arterial pressure by analysis of covariance.
A  late diastolic ﬁlling velocity; Am  late diastolic tissue velocity; DT  de
diastolic ﬁlling velocity; EDVI  end-diastolic volume index; Em  early diasto
end-systolic volume index; LV  left ventricular; Sm  systolic tissue velocity
Table 1.N Status
s Without
n  98) p Value
 9 0.35
 4 0.91
 6 0.21
 0.3 0.39
 6 0.69
 21 0.051
 0.1 0.010
 0.2 0.001
 0.2 0.27
 54 0.47
 1.0 0.001
 1.3 0.001
 1.4 0.94
 0.3 0.011
 9 0.70
 3 0.087
 6 0.20
 1.0 0.016
 6 0.006
 2.0 0.001
 2.0 0.59
 2.1 0.62
 0.2 0.38
 1.6 0.32
 6 0.50
 0.9 0.005
 7 0.045
 1.4 0.022
riables were corrected for
celeration time; E  early
lic tissue velocity; ESVI 
; other abbreviation as inhe mid-anterior (r  0.34, p  0.08) and
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1212id-lateral walls (r  0.33, p  0.09). Indepen-
ent associations of regional tracer activity with
m were sought using a multiple linear regres-
ion model including H/M ratio (to control for
lobal 123I-MIBG uptake) and age, which repre-
ented the strongest predictor of global diastolic
unction. Regional 123I-MIBG uptake was inde-
endently associated with regional Em exclu-
ively in the mid-anterior (  0.45, p  0.01,
djusted R2  0.32) and mid-lateral walls ( 
.34, p  0.03, adjusted R2  0.43). No associ-
tions were found between regional 123I-MIBG
ptake and regional Sm.
Synchrony analyses did not reveal associations
f regional 123I-MIBG uptake with times to peak
m or Em (after correcting for HR) in any
egment. To determine whether regional dener-
ation triggered global systolic or diastolic dys-
ynchrony, we compared SDs of times to peak
Table 3. Prevalence of Diastolic Dysfunction by CAN Status
Patients
With
CAN
Patients
Without
CAN Total
Normal diastolic function 1 (6) 66 (67) 67
Grade 1 diastolic dysfunction 6 (38) 16 (16) 22
Grade 2 diastolic dysfunction 9 (56) 16 (16) 25
Total 16 (100) 98 (100) 114
Data indicate n (%) of patients with various classiﬁcations of diastolic function
according to CAN status. Patients with CAN demonstrated higher diastolic
dysfunction grade (Mann-Whitney U test; p  0.001).
Abbreviation as in Table 1.
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 (c
m
/s
)
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r=0.42, p<0.001
Figure 1. Association of CAN and Diastolic Function
Correlations of mean early diastolic tissue velocity (Em), measured i
ing, with total spectral power of heart rate variability (A) and ratio
heart and mediastinum (H/M ratio) (B). Patients with cardiac autonomicm and Em across quartiles of 123I-MIBG up-
ake in each wall; however, no group differences
ere identified (p  0.10 for all).
I S C U S S I O N
his study demonstrated that the global relation-
hips of CAN and LV dysfunction remain indepen-
ent of known factors in the pathogenesis of myo-
ardial disease and reflect underlying regional
elationships of sympathetic integrity and function.
hese findings support the existence of a distinct
utonomic cardiopathy in the setting of DCM,
lbeit a difficult syndrome to characterize in isola-
ion. Our data indicate that resting diastolic dys-
unction is a key feature, based on independent
ssociations of CAN markers with resting Em, but
ot Sm or LV functional reserve parameters. None-
heless, patients with fully evolved CAN demon-
trate a variety of LV functional deficits, including
ystolic and diastolic dysfunction at rest and re-
uced systolic functional reserve. The divergent
ndings may be attributed to an association of
AN with additional mechanisms of DCM,
hereby several factors contribute to heterogeneous
V functional abnormalities in patients with ad-
anced disease.
CM and CAN. The parallel association of reduced
m with global CAN based on clinical assessment
nd myocardial uptake of 123I-MIBG, in addition
o the independent regional association in the free
H/M Ratio
2.0
3.0
4.0
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7.0
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CAN+
r=0.41, p=0.017
basal left ventricular segments using color tissue Doppler imag-
elayed (4-h) uptake of iodine 123-metaiodobenzylguanidine in the5
1
B
n 6
of dneuropathy (CAN) are shown in orange.
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1213all (mid-anterior and lateral walls) suggests that
he diastolic impairment central to autonomic car-
iopathy is linked to cardiac sympathetic denerva-
ion. These results concur with previously reported
orrelations between CAN and altered LV filling
atterns, mainly in type 1 diabetes mellitus (7–11)
ut also in T2DM (12), in addition to associations
f global sympathetic denervation with diastolic
ysfunction in type 1 diabetes mellitus (25,26). The
resent study builds on previous findings by defin-
ng regional associations accompanying the inde-
endent global association in T2DM, for which the
athophysiology of LV dysfunction may be mark-
dly different compared with type 1 diabetes melli-
us due to increased contributions from insulin
esistance, obesity, and hypertension.
CAN represents one of numerous mechanisms in
he multifactorial etiology of DCM, which may
nclude contributions from metabolic abnormalities,
nterstitial fibrosis, and microvascular disease (1).
ndeed, we observed diastolic dysfunction in 30%
f patients without CAN. Potential heterogeneity
n manifestations of diastolic dysfunction is high-
ighted in the present study, evidenced by preserved
iastolic functional reserve with CAN. This unex-
ected result may be attributed to differential rela-
ionships of myocardial functional abnormalities
ith the spectrum of contributing pathologies.
The regional heterogeneity of the association of
CM and CAN likely reflects the variable pattern
f sympathetic denervation, showing regional asso-
iations exclusively in the denervated walls (anterior
nd lateral). However, we found no evidence that
hese regional differences cause mechanical dyssyn-
hrony. We were unable to determine potential
ssociations in the inferior wall in the present study,
lthough its involvement is possible in light of
revious reports of abnormal tracer kinetics in this
egion in diabetic patients (14). The finding of
egional associations in mid-, but not basal seg-
ents also deserves comment and may be related to
he base-to-apex gradient of sympathetic dysinner-
ation shown in diabetic patients using 11C-labeled
ydroxyephedrine positron emission tomography
14). This is characterized by proximal hyperinner-
ation accompanying distal denervation, which
ould explain the association of mid-segmental
ympathetic denervation with comparatively greater
eductions in Em. Although 123I-MIBG uptake
as reduced in some basal segments in the current
tudy, these findings must be considered in the
ontext of the limitations of 123I-MIBG SPECT,
hich, in contrast to positron emission tomogra- phy, precludes absolute quantification of regional
ympathetic integrity.
Systolic dysfunction with reduced contractile re-
erve was also observed in patients with CAN;
owever, the lack of an independent global or
egional association with markers of autonomic
unction indicates that these abnormalities are not
irect manifestations of an autonomic cardiopathy.
revious reports in type 1 diabetes mellitus have
lso identified evidence of impaired contractile re-
erve with CAN, characterized by reduced exercise
jection fraction (27,28) and end-systolic pressure-
olume ratio (27). The current finding of an inde-
endent association between Sm reserve and chro-
otropic index indicates that these results may be
ttributed to chronotropic incompetence in patients
ith CAN.
tudy limitations. Fully evolved CAN was identified
n a relatively small proportion of patients (14%).
his was lower than 34% identified in a similarly
nselected population using equivalent diagnostic
riteria (5) and may reflect a more favorable risk
actor profile for microvascular complications in our
tudy population. This may have limited our capac-
ty to detect differences in various myocardial func-
ional parameters. However, preclinical abnormali-
ies in autonomic function occur progressively with
volution of T2DM and before manifestation as
vert neuropathy; indeed, myocardial sympathetic
ysinnervation has been identified in 40% of dia-
etic patients not meeting clinical criteria for CAN
14). We assessed cardiac autonomic function with
ufficient sensitivity to demonstrate a relationship
ith LV function across a wide spectrum of disease
everity, in addition to the association of reduced
unction with definite CAN. However, considering
he sizable number of covariates, a larger study
opulation may have been beneficial; likewise, the
erformance of myocardial scintigraphy in only a
elatively small subgroup is also recognized. Finally,
e acknowledge that the more adverse clinical
tatus of patients with CAN presented difficulties in
solating the direct effects of this complication on
V function, even after statistical adjustment.
orse metabolic control with CAN may represent
particularly important mechanism underlying as-
ociations with DCM, despite the lack of a rela-
ionship of HbA1c with LV function. This might be
larified using more sensitive constructs of meta-
olic milieu based on longitudinal markers of dis-
ase severity.
linical relevance. This study has confirmed the
resence of an autonomic cardiopathy in apparently
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1214ealthy patients with T2DM and an independent
ssociation with resting diastolic dysfunction, a key
omponent of DCM. Moreover, the independent
ssociations of regional sympathetic integrity with
egional function suggest a closer link than one
ediated by common etiology alone. Whether this
s a specific attribute of DCM or might be seen in
ther subclinical heart disease warrants further
tudy. In the absence of definitive evidence support-
ng direct treatment, the current management ofventriculography study. Diabetes Care
2003;26:1955–60.
Improved perfo
segment depressionmprove glycemic control. Angiotensin-converting
nzyme inhibitor and/or angiotensin receptor
locker therapy (29) have shown promising initial
esults, although further clinical trials are required
o determine their efficacy and potential for trans-
ation of benefits to LV function.
eprint requests and correspondence: Dr. Thomas H.
arwick, Cardiovascular Imaging, J1-5, Cleveland
linic, 9500 Euclid Avenue, Cleveland, Ohio 44122.
diabetic CAN relies on aggressive strategies to E-mail: marwict@ccf.org.1
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